QuidelOrtho Corp (QDEL) stock
QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)
Close on Nov 17, 2026Market cap $676.84MP/E –Yield –
QuidelOrtho EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
QuidelOrtho's EV/EBITDA was 10.7× on Nov 11, 2026, against 11.0× a year earlier. Over the last 4 years it ranged from 2.3× to 21.6×, with a median of 6.4×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.7× | −10.0 |
| 2025 | Oct 31, 2025 | 20.8× | +12.5 |
| 2024 | Apr 30, 2024 | 8.3× | −3.2 |
| 2023 | Dec 29, 2023 | 11.5× | +5.2 |
| 2022 | Dec 30, 2022 | 6.3× | +1.4 |
| 2021 | Dec 31, 2021 | 4.9× | – |
See a number that looks wrong?